Home / Stocks / Jubilant Ingrevia Limited
JUBLINGREA

Jubilant Ingrevia Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹573.7

Change

-13.15 (-2.24%)

Open

₹584.95

Prev. Close

₹586.85

Day High

₹587.2

Day Low

₹572.0

Volume Analysis

Traded

202,605

Delivered

108,179

Delivery %

53.39%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (2)

  • •Low return on equity (9.52%)
  • •Promoter holding is falling

Opportunities (1)

  • •FII holding has been rising

Threats (0)

No signal for this stock

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹598.46 ₹592.83 ₹583.26 ₹577.63 ₹568.06 ₹562.43 ₹552.86
Fibonacci ₹592.83 ₹587.02 ₹583.44 ₹577.63 ₹571.82 ₹568.24 ₹562.43
Camarilla ₹577.88 ₹576.49 ₹575.09 ₹577.63 ₹572.31 ₹570.91 ₹569.52

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-18.85%

1 Week

-4.36%

1 Month

-3.89%

3 Months

-20.14%

6 Months

-21.17%

1 Year

-20.79%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹285.77

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

9.42%

Net margin 7.13% × asset turnover 0.73x × equity multiplier 1.81x

Company Overview

Sector

Chemicals

Market Cap

₹9,340 Cr

P/E (TTM)

26.0

ROE

9.52%

Book Value

₹208.0

Face Value

₹1.0

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Jubilant Ingrevia Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 61/100. The strongest factor is Financial Strength (100/100), while Momentum (20/100) is the weakest area to weigh before deciding. Notably: Low return on equity (9.52%); promoter holding is falling. FII holding has been rising.

TopFund Score — Fundamentals Quality

61/100 — Average

Data confidence: 80/100 (High Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

50

Valuation

52

Cash Flow

64

Corporate Governance

76

Momentum

20

Institutional Ownership

73

Business Quality

55

Risk & Volatility

45

Liquidity

62

From Screener.in

  • +Company has been maintaining a healthy dividend payout of 34.4%
  • +Company's working capital requirements have reduced from 29.4 days to 22.0 days
  • −Stock is trading at 2.83 times its book value
  • −Company has a low return on equity of 8.49% over last 3 years.
  • −Promoter holding has decreased over last 3 years: -6.25%

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Management of the Company will be participating in Kotak Midcap Conference 2026 scheduled on 26th & 27th November, 2026

JAEL executed SSPA to acquire 40% of Zettaone, with option to raise stake to 51% in FY28.

Newspaper advertisement for dispatch of postal ballot notice

Transcript of the Investors'' Conference Call for un-audited standalone and consolidated financial results for the quarter and half year ended September 30, 2026, held on …

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 1,020 966 1,074 1,024 1,045 1,057 1,051 1,038 1,121 1,051 1,179 1,300 1,394
Expenses + 902 871 983 915 921 918 905 896 985 924 1,016 1,101 1,182
Operating Profit 118 96 91 110 124 138 147 142 135 126 163 199 212
OPM % 12.0% 10.0% 8.0% 11.0% 12.0% 13.0% 14.0% 14.0% 12.0% 12.0% 14.0% 15.0% 15.0%
Other Income + 9 9 10 10 10 9 8 11 11 -4 9 10 9
Interest 13 15 14 14 15 12 14 13 12 12 12 17 22
Depreciation 34 34 36 39 40 40 39 41 41 45 48 51 51
Profit before tax 80 55 51 66 80 96 102 100 93 65 112 141 148
Tax % 28.0% 30.0% 43.0% 26.0% 26.0% 27.0% 27.0% 25.0% 25.0% 28.0% 23.0% 25.0% 25.0%
Net Profit + 57 39 29 49 59 69 74 75 69 47 86 106 111
EPS in Rs 4 2 2 3 4 4 5 5 4 3 5 7 7
Raw PDF — — — — — — — — — — — — —
YoY Sales growth -22 -17 -6 -5 2 9 -2 1 7 -1 12 25 24

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 0 684 4,949 4,773 4,136 4,178 4,388 4,924
Expenses + 0 567 4,108 4,224 3,708 3,658 3,820 4,224
Operating Profit 0 117 841 549 427 519 568 700
OPM % — 17.0% 17.0% 11.0% 10.0% 12.0% 13.0% 14.0%
Other Income + 0 -10 22 32 29 38 27 25
Interest 0 7 31 22 53 56 49 64
Depreciation 0 22 123 122 136 158 175 195
Profit before tax 0 77 709 437 268 344 370 466
Tax % 0.0% 30.0% 33.0% 30.0% 32.0% 27.0% 25.0% —
Net Profit + 0 54 477 308 183 251 278 351
EPS in Rs -3 3 30 19 11 16 17 22
Dividend Payout % 0.0% 10.0% 17.0% 26.0% 43.0% 31.0% 28.0% —
Sales growth — — 623 -4 -13 1 5 15

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 0 1,907 2,417 2,650 2,722 2,911 3,110 3,301
Borrowings + 0 556 238 407 740 764 792 895
Other Liabilities + 0 888 1,111 1,176 1,241 1,324 1,551 1,787
Total Liabilities 0 3,366 3,782 4,249 4,719 5,015 5,470 5,999
Fixed Assets + 0 1,805 1,798 1,846 2,539 2,581 3,183 3,157
CWIP 0 65 174 525 331 525 154 281
Investments 0 50 6 8 15 37 33 37
Other Assets + 0 1,446 1,804 1,870 1,834 1,872 2,099 2,524
Total Assets 0 3,366 3,782 4,249 4,719 5,015 5,470 5,999
Equity Capital 0 16 16 16 16 16 16 16

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 0 112 453 462 430 508 524
Cash from Investing Activity + 0 33 -71 -469 -568 -389 -250
Cash from Financing Activity + 0 -72 -418 42 144 -129 -155
Net Cash Flow 0 73 -36 35 6 -9 119
Free Cash Flow 0 85 225 -16 -136 156 235
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 0 106 69 98 111 113 111

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 51.47% → 45.22%
  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Others 0.82% 0.81% 0.81% 0.77% 0.74% 0.73% 0.72% 0.82% 0.8% 0.98% 0.98% 0.96%
Public 30.17% 27.53% 27.1% 25.09% 24.9% 24.76% 25.3% 24.94% 23.8% 22.53% 22.3% 21.69%
Promoters 51.47% 51.47% 51.47% 51.47% 51.47% 51.47% 45.22% 45.22% 45.22% 45.22% 45.22% 45.22%
Government 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.02% 0.02% 0.02% 0.02% 0.02%
FII 6.35% 6.58% 6.55% 7.22% 6.89% 7.12% 6.96% 5.96% 6.15% 6.49% 6.49% 6.93%
DII 11.17% 13.6% 14.07% 15.47% 15.99% 15.91% 21.81% 23.04% 24.0% 24.76% 24.98% 25.18%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Chemicals — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Jubilant Ingrevia Limited (this stock) 9,340 26.0 2.82 9.52%
Sudarshan Chemical Inds L 9,219 61.2 2.52 0.54%
Neogen Chemicals Limited 8,526 211.0 5.41 3.58%
Alkyl Amines Chem. Ltd 8,235 43.4 15.33 41.4%
Galaxy Surfactants Ltd 7,852 18.8 2.64 10.9%
Pcbl Chemical Limited 11,117 40.1 2.75 5.56%
Clean Science & Tech Ltd 7,524 32.3 4.5 15.3%

Which Mutual Funds Hold Jubilant Ingrevia Limited?

Frequently Asked Questions about Jubilant Ingrevia Limited

Community Sentiment

What are other investors saying about Jubilant Ingrevia Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.